Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines
- PMID: 18673516
- PMCID: PMC2500108
- DOI: 10.1186/1746-1596-3-S1-S27
Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines
Abstract
Background: Tissue microarrays (TMAs) are used to study genomics and proteomics in several tumour tissue samples. Cell lines (CC) are of great importance in the study of the genetic changes in tumours, and some reveal several aspects of tumour oncogenesis. There are few published reports on Ewing's tumours with TMAs including original tumours (OT) and corresponding CC.
Methods: We have performed four TMAs, from 3 OT and the corresponding CC of successive in vivo and in vitro tumour passages. Xenotransplant CC in nude mice from OT (XT/OT) was made. Subsequently multiple XT were performed and in vitro XT cell line (CC/XT) was obtained. In vivo re-inoculation of CC/XT (XT/CC) was planned. TMAs with the successive tumour passages that grew in nude mice (XT/OT and XT/CC) were analyzed by morphologic pattern (Hematoxilin/eosin), immunohistochemical staining (CD99, FLI1, p16, p53, ki-67), fluorescent in situ hybridization-FISH-(EWSR1 break apart, p16 and p53 status) and gene fusion types.
Results: Heterogeneous results of the p16, p53 and ki67 in OT, XT/OT, CC/XT and XT/CC were observed. The three cell lines revealed EWS/FLI1 rearrangements. p16 gene was deleted only in one case. The deletion was detected by FISH and confirmed by PCR assays. A p53 alteration was found in the second case with monosomy and subsequently polysomic status of chromosome 17 during the evolution of CC. The PCR study revealed p53 mutation. The third case showed hypermethylation in the promoter of p16. The growth of the tumour in nude mice was more accelerated when the inoculation was performed from the CC/XT, increasing progressively over the passages. The third case did not reveal tumour growth in nude mice after the re-inoculation of CC/XT.
Conclusion: The study of several cores from original tumours and successive tumour passages in TMAs facilitated the analysis of the genetic alteration and protein expression in Ewing's tumours.
Similar articles
-
Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study.Diagn Pathol. 2008 Jul 15;3 Suppl 1(Suppl 1):S25. doi: 10.1186/1746-1596-3-S1-S25. Diagn Pathol. 2008. PMID: 18673514 Free PMC article.
-
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.Nat Genet. 1999 Oct;23(2):222-7. doi: 10.1038/13854. Nat Genet. 1999. PMID: 10508522
-
DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.Oncogene. 2008 Oct 9;27(46):6034-43. doi: 10.1038/onc.2008.203. Epub 2008 Jun 30. Oncogene. 2008. PMID: 18591936
-
EWS-FLI1 and Ewing's sarcoma: recent molecular data and new insights.Cancer Biol Ther. 2002 Jul-Aug;1(4):330-6. Cancer Biol Ther. 2002. PMID: 12432241 Review.
-
Molecular mechanism of hepatocarcinogenesis.J Gastroenterol Hepatol. 1997 Oct;12(9-10):S309-13. doi: 10.1111/j.1440-1746.1997.tb00514.x. J Gastroenterol Hepatol. 1997. PMID: 9407351 Review.
References
-
- Kramer MW, Merseburger AS, Hennenlotter J, Kuczyk M. Tissue microarrays in clinical urology – Technical considerations. Scand J Urol Nephrol. 2007. pp. 1–7. - PubMed
-
- Merseburger AS, Kuczyk MA, Serth J, Bokemeyer C, Young DY, Sun L, et al. Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. Oncol Rep. 2003;10:223–228. - PubMed
-
- Tubbs RR, Pettay J, Barry TS, Swain E, Loftus M, Cook JR, et al. The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts. J Mol Histol. 2007;38:159–165. doi: 10.1007/s10735-006-9066-1. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous